Breaking News Instant updates and real-time market news.

UAL

United Continental

$83.77

1.39 (1.69%)

, ALK

Alaska Air

$62.19

1.585 (2.62%)

06:53
01/10/19
01/10
06:53
01/10/19
06:53

JPMorgan upgrades United and Alaska Air, downgrades JetBlue

JPMorgan analyst Jamie Baker raised his 2019 estimates "across the board" for the U.S. Airlines ahead of next week's earnings kickoff. However, he says the earnings raises are for the "wrong reasons," namely cheaper fuel and softer RASM. JetBlue Airways' (JBLU) forecasted upside potential falls below 10% after the analyst reduced his target multiples. As such, he downgraded the shares to Neutral from Overweight. The analyst also upgraded Alkaska Air Group (ALK) to Neutral from Underweight rating saying his 2020 earnings forecast for the company is the only one to rise materially. In addition, the analyst upgraded United Continental Holdings (UAL) to Overweight from Neutral. The analyst sees an attractive risk/reward profile following the stock's 14% selloff from just five weeks ago.

UAL

United Continental

$83.77

1.39 (1.69%)

ALK

Alaska Air

$62.19

1.585 (2.62%)

JBLU

JetBlue

$17.24

0.38 (2.25%)

  • 16

    Jan

  • 24

    Jan

  • 04

    Mar

UAL United Continental
$83.77

1.39 (1.69%)

01/09/19
IMPC
01/09/19
DOWNGRADE
Target $73
IMPC
Underperform
United Continental downgraded to Underperform from In-Line at Imperial Capital
Imperial Capital analyst Michael Derchin downgraded United Continental Holdings (UAL) to Underperform and lowered his price target for the shares to $73 from $110. Following Delta's (DAL) Q4 update, further declines in fuel prices and recent market volatility, the analyst reduced his valuations and unit revenue expectations "across the board to reflect conservatism." Among his baseline industry assumptions is the expectation for fewer fare increases by low cost carriers due to lower oil prices. United's unit revenue momentum is likely to slow meaningfully through fiscal 2020, resulting in shares trading at similar valuations as American Airlines (AAL), Derchin tells investors in a research note.
01/10/19
JPMS
01/10/19
UPGRADE
Target $95
JPMS
Overweight
United Continental upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jamie Baker upgraded United Continental Holdings to Overweight with a $95 price target.
01/09/19
01/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Neutral from Outperform at Baird with analyst Jonathan Komp citing its relative valuation and concerns about its high P/E premium. 2. Oracle (ORCL) downgraded to Equal Weight from Overweight at Barclays with analyst Raimo Lenscho saying the competitive situation in the company's core database market and cloud is "not getting easier." 3. Wendy's (WEN) downgraded to Neutral from Outperform at Wedbush. 4. Booking Holdings (BKNG) downgraded to Equal Weight from Overweight at Morgan Stanley and to Hold from Buy at Jefferies. 5. United Continental (UAL) downgraded to Underperform from In-Line at Imperial Capital while Delta Air Lines (DAL) was downgraded to In-Line from Outperform. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/18/18
COWN
12/18/18
NO CHANGE
COWN
Outperform
ExpressJet sale 'hugely positive' for SkyWest shares, says Cowen
Cowen analyst Helane Becker says SkyWest's (SKYW) sale of ExpressJet to United Airlines joint venture ManaAir will remove a "significant overhang" for SkyWest as ExpressJet has been a drag on profitability for since the acquisition. The sale is "hugely positive" for SkyWest shares, Becker tells investors in a research note. The analyst sees improved profitability of the company going forward. She also views the transaction as neutral for United Continental (UAL) shares. SkyWest is up 4% to $46.64 in early trading while United Continental is up 3% to $88.63.
ALK Alaska Air
$62.19

1.585 (2.62%)

12/17/18
IMPC
12/17/18
NO CHANGE
Target $102
IMPC
Outperform
Alaska Air called a top idea for 2019 at Imperial Capital
Imperial Capital analyst Michael Derchin says Alaska Air is among his firm's top ideas and admits he be underestimating its revenue potential. He estimates Alaska Air's "industry-leading" unit revenue growth at 5% in fiscal 2019, which he feels could be conservative due to the company's "significant" pricing power, minimal headwinds from new markets, healthy demand in all core West Coast markets and easing year-over-year comparisons in legacy Virgin America markets. The analyst keeps an Outperform rating on the shares with a $102 price target.
01/09/19
IMPC
01/09/19
NO CHANGE
Target $90
IMPC
Outperform
Alaska Air price target lowered to $90 from $102 at Imperial Capital
Imperial Capital analyst Michael Derchin lowered his price target for Alaska Air Group (ALK) to $90 while keeping an Outperform rating on the shares. Following Delta's (DAL) Q4 update, further declines in fuel prices and recent market volatility, the analyst reduced his valuations and unit revenue expectations "across the board to reflect conservatism." However, he says Alaska Air is among his top ideas and that he could be underestimating its revenue potential.
11/29/18
IMPC
11/29/18
NO CHANGE
Target $102
IMPC
Outperform
Alaska Air price target raised to $102 from $90 at Imperial Capital
Imperial Capital analyst Michael Derchin raised his price target for Alaska Air Group to $102 and keeps an Outperform rating on the shares following the company's investor day and Q4 guidance. Alaska Air is likely to lead the industry in unit revenue growth in fiscal 2020, and its revenue potential could be underestimated considering its minimal capacity growth and merger synergies, Derchin tells investors in a research note.
01/10/19
JPMS
01/10/19
UPGRADE
Target $67
JPMS
Neutral
Alaska Air upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Jamie Baker upgraded Alaska Air Group to Neutral and raised his price target for the shares to $67 from $62.
JBLU JetBlue
$17.24

0.38 (2.25%)

11/19/18
FBCO
11/19/18
INITIATION
Target $16
FBCO
Underperform
JetBlue initiated with an Underperform at Credit Suisse
Credit Suisse analyst Jose Caiado started JetBlue Airways with an Underperform rating and $16 price target. Optimism for 2019 margin expansion is overdone, Caiado tells investors in a research note. He wants to wait for consensus estimates to reset closer to his below-Street forecasts. The bulk of JetBlue's revenue initiatives don't kick in meaningfully until later in 2019, and comps in the first half of the year will be tough given the recent pilot deal, "making this more of a 2020 story," says the analyst.
12/07/18
WOLF
12/07/18
DOWNGRADE
WOLF
Underperform
JetBlue downgraded to Underperform from Peer Perform at Wolfe Research
12/04/18
IMPC
12/04/18
NO CHANGE
Target $27
IMPC
Outperform
JetBlue price target raised to $27 from $24 at Imperial Capital
Imperial Capital analyst Michael Derchin raised his price target for JetBlue Airways to $27 saying the company is likely to raise its Q4 guidance following the better than outlook from some peers. He believes the Street is underestimating JetBlue's ability to reach its $2.50-$3.00 fiscal 2020 earnings target and keeps an Outperform rating on the shares.
01/10/19
JPMS
01/10/19
DOWNGRADE
Target $18
JPMS
Neutral
JetBlue downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jamie Baker downgraded JetBlue Airways to Neutral and lowered his price target for the shares to $18 from $20.

TODAY'S FREE FLY STORIES

KMB

Kimberly-Clark

$115.15

-1.675 (-1.43%)

07:30
01/23/19
01/23
07:30
01/23/19
07:30
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 28

    May

KMB

Kimberly-Clark

$115.15

-1.675 (-1.43%)

07:30
01/23/19
01/23
07:30
01/23/19
07:30
Earnings
Kimberly-Clark reports Q4 adjusted EPS $1.60, consensus $1.65 »

Reports Q4 revenue $4.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 28

    May

F

Ford

$8.51

-0.08 (-0.93%)

, FCAU

Fiat Chrysler

$16.51

-0.275 (-1.64%)

07:30
01/23/19
01/23
07:30
01/23/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

F

Ford

$8.51

-0.08 (-0.93%)

FCAU

Fiat Chrysler

$16.51

-0.275 (-1.64%)

MO

Altria Group

$44.98

-3.31 (-6.85%)

STX

Seagate

$38.49

-1.76 (-4.37%)

KSS

Kohl's

$69.32

-0.61 (-0.87%)

SWK

Stanley Black & Decker

$115.65

-21.26 (-15.53%)

PAAS

Pan American Silver

$13.20

-0.97 (-6.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 31

    Jan

  • 04

    Feb

  • 07

    Feb

  • 18

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

07:30
01/23/19
01/23
07:30
01/23/19
07:30
General news
Stock market sentiment has started to stabilise »

Stock market sentiment…

LRCX

Lam Research

$139.82

-7.69 (-5.21%)

, AMAT

Applied Materials

$34.44

-1.27 (-3.56%)

07:29
01/23/19
01/23
07:29
01/23/19
07:29
Recommendations
Lam Research, Applied Materials, KLA-Tencor, Brooks Automation analyst commentary  »

Citi moves Lam Research…

LRCX

Lam Research

$139.82

-7.69 (-5.21%)

AMAT

Applied Materials

$34.44

-1.27 (-3.56%)

KLAC

KLA-Tencor

$93.17

-2.54 (-2.65%)

BRKS

Brooks Automation

$27.78

-1.32 (-4.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Feb

  • 25

    Mar

  • 26

    Mar

  • 28

    May

MTOR

Meritor

$19.64

-0.36 (-1.80%)

07:29
01/23/19
01/23
07:29
01/23/19
07:29
Downgrade
Meritor rating change  »

Meritor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 29

    Jan

COF

Capital One

$83.38

-1.62 (-1.91%)

07:28
01/23/19
01/23
07:28
01/23/19
07:28
Downgrade
Capital One rating change  »

Capital One downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

APOP

Cellect Biotechnology

$2.79

(0.00%)

07:27
01/23/19
01/23
07:27
01/23/19
07:27
Hot Stocks
Cellect Biotechnology reports clinical and regulatory milestone targets »

Cellect Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPX

Continental Building

$25.55

-0.32 (-1.24%)

07:25
01/23/19
01/23
07:25
01/23/19
07:25
Downgrade
Continental Building rating change  »

Continental Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$125.28

-4.68 (-3.60%)

07:25
01/23/19
01/23
07:25
01/23/19
07:25
Recommendations
Bluebird Bio analyst commentary  »

Bluebird Bio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,634.15

-61.86 (-3.65%)

07:24
01/23/19
01/23
07:24
01/23/19
07:24
Recommendations
Amazon.com analyst commentary  »

Amazon Q4 results should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 28

    Jan

  • 31

    Jan

  • 04

    Feb

  • 20

    Feb

  • 03

    Mar

REPL

Replimune Group

$10.60

0.15 (1.44%)

07:24
01/23/19
01/23
07:24
01/23/19
07:24
Downgrade
Replimune Group rating change  »

Replimune Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$91.33

-0.13 (-0.14%)

07:23
01/23/19
01/23
07:23
01/23/19
07:23
Downgrade
Neurocrine rating change  »

Neurocrine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

WMT

Walmart

$97.47

-0.28 (-0.29%)

07:23
01/23/19
01/23
07:23
01/23/19
07:23
Upgrade
Walmart rating change  »

Morgan Stanley upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GTX

Garrett Motion

$15.24

-0.56 (-3.54%)

07:22
01/23/19
01/23
07:22
01/23/19
07:22
Upgrade
Garrett Motion rating change  »

Garrett Motion upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LJPC

La Jolla

$6.04

-0.24 (-3.82%)

07:22
01/23/19
01/23
07:22
01/23/19
07:22
Upgrade
La Jolla rating change  »

La Jolla upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTHX

G1 Therapeutics

$19.56

-0.56 (-2.78%)

07:21
01/23/19
01/23
07:21
01/23/19
07:21
Downgrade
G1 Therapeutics rating change  »

G1 Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIDX

Eidos Therapeutics

$12.64

-0.04 (-0.32%)

07:20
01/23/19
01/23
07:20
01/23/19
07:20
Downgrade
Eidos Therapeutics rating change  »

Eidos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXCYY

Metso

$0.00

(0.00%)

07:20
01/23/19
01/23
07:20
01/23/19
07:20
Hot Stocks
Metso's Shareholders' Nomination Board to propose Mikael Lilius as chair »

Metso's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$7.76

-0.47 (-5.71%)

07:20
01/23/19
01/23
07:20
01/23/19
07:20
Downgrade
Dova Pharmaceuticals rating change  »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 30

    Jun

APLS

Apellis

$13.46

-1.42 (-9.54%)

07:19
01/23/19
01/23
07:19
01/23/19
07:19
Downgrade
Apellis rating change  »

Apellis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$298.80

-3.46 (-1.14%)

07:18
01/23/19
01/23
07:18
01/23/19
07:18
Downgrade
Tesla rating change  »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

IP

International Paper

$45.69

0.03 (0.07%)

07:15
01/23/19
01/23
07:15
01/23/19
07:15
Upgrade
International Paper rating change  »

Stephens says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

EHTH

eHealth

$45.38

-0.85 (-1.84%)

07:15
01/23/19
01/23
07:15
01/23/19
07:15
Recommendations
eHealth analyst commentary  »

eHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

07:15
01/23/19
01/23
07:15
01/23/19
07:15
General news
FX Update: The dollar has traded flat-to-softer »

FX Update: The dollar has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.